• Thumbnail for AbbVie
    87°50′04″W / 42.33679°N 87.83432°W / 42.33679; -87.83432 (Headquarters Site) AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago...
    41 KB (3,428 words) - 18:58, 21 September 2024
  • Results - AbbVie News Center". news.abbvie.com. "Financial Release - AbbVie". investors.abbvie.com. "Financial Release - AbbVie". investors.abbvie.com. "Financial...
    62 KB (2,735 words) - 16:33, 29 August 2024
  • Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper...
    11 KB (972 words) - 18:51, 18 July 2024
  • chairman of Cerevel. In December 2023, American pharmaceutical company AbbVie announced its intention to acquire Cerevel for US$8.7 billion. The acquisition...
    10 KB (802 words) - 16:07, 12 August 2024
  • Thumbnail for Besins Healthcare
    conditions. In November 2022, Oregon Attorney General Ellen Rosenblum sued AbbVie, Abbott Laboratories, Unimed Pharmaceuticals. The lawsuit alleges that the...
    4 KB (331 words) - 10:48, 11 June 2024
  • £1.7billion. On 20 June 2014, Shire rejected a takeover attempt by AbbVie. AbbVie offered £46.11 per share (£27.3 billion or $46.5 billion in total)....
    41 KB (3,016 words) - 23:29, 12 September 2024
  • Thumbnail for Atogepant
    Atogepant (category Drugs developed by AbbVie)
    days per month. Atogepant was developed by the biopharmaceutical company AbbVie. The benefits and side effects of atogepant were evaluated in two clinical...
    12 KB (793 words) - 18:24, 17 August 2024
  • Thumbnail for Ibrutinib
    Ibrutinib (category Drugs developed by AbbVie)
    and $825 million in milestones. Pharmacyclics was acquired by AbbVie in May 2015, and Abbvie projected global sales of US$1 billion in 2016 and $5 billion...
    29 KB (2,605 words) - 21:22, 16 August 2024
  • Pharmacyclics (category AbbVie)
    commercial product. In March 2015, Chicago-based biopharmaceutical firm AbbVie announced it would acquire Pharmacyclics, as well as its lead anti-cancer...
    6 KB (321 words) - 18:21, 18 December 2023
  • and AbbVie announced an R&D collaboration focused on aging and age-related diseases such as neurodegeneration and cancer. Working together with AbbVie, Calico...
    14 KB (1,102 words) - 06:42, 3 July 2024